Post by LymeEnigma on Aug 16, 2008 10:02:12 GMT -8
ANA: Neurological Impairment Seen in Patients Given Lymerix Lyme Disease Vaccine
By Ed Susman
Special to DG News
NEW YORK, NY -- October 16, 2002 -- Doctors treating patients at the Peripheral Neuropathy Center of Cornell-New York Hospital have identified nine people with neuropathies or encephalopathies linked to vaccination with Lymerix.
Howard Sander, MD, associate professor of clinical neurology at the Weill Medical School at Cornell, said the patients treated represent only those with neurological complications of the vaccine, which was taken off the market due to several reports of various side effects after being administered to more than a million people.
In a presentation here October 15 at the 127th annual meeting of the American Neurological Association (ANA), researchers reviewed those neurological cases.
Dr. Anita Wu, MD, a fellow in neurology at the hospital and lead author of the poster study, said four patients were being treated for neuropathies; four for encephalopathies and one patient appeared to have both neuropathy and encephalopathy complaints.
"We are not certain whether the patients developed these conditions from the vaccine or possibly from Borrelia burgdorferi infection," she said. B. burgdorferi is the bacterium that is transmitted by infected ticks to humans, causing a wide spectrum of symptoms, from rash to neurological impairment.
Dr. Sander noted that the investigators have only been tracking these neurological complications for a year. "We want to put it on the map that the vaccine can be linked to these conditions. This is just the tip of the iceberg," she said.
Dr. Armin Alaedini, PhD, also a fellow in neurology and another co-author of the study, noted that in hearings before the Food and Drug Administration many individuals reported a variety of symptoms following Lymerix vaccination.
The researchers scrutinised the genetic sequencing of key amino acids found in the patients and in various databases. They said their work considered that the neurological sequelae of Lymerix vaccination, and possibly chronic Lyme disease, might be caused by molecular mimicry, resulting from reactions to part of the vaccine proteins.
Dr. Wu said one patient suffering from a neuropathy had responded to standard treatments. She said that the presentation did not receive any outside funding.
www.pslgroup.com/dg/220652.htm
All emphasis mine.
By Ed Susman
Special to DG News
NEW YORK, NY -- October 16, 2002 -- Doctors treating patients at the Peripheral Neuropathy Center of Cornell-New York Hospital have identified nine people with neuropathies or encephalopathies linked to vaccination with Lymerix.
Howard Sander, MD, associate professor of clinical neurology at the Weill Medical School at Cornell, said the patients treated represent only those with neurological complications of the vaccine, which was taken off the market due to several reports of various side effects after being administered to more than a million people.
In a presentation here October 15 at the 127th annual meeting of the American Neurological Association (ANA), researchers reviewed those neurological cases.
Dr. Anita Wu, MD, a fellow in neurology at the hospital and lead author of the poster study, said four patients were being treated for neuropathies; four for encephalopathies and one patient appeared to have both neuropathy and encephalopathy complaints.
"We are not certain whether the patients developed these conditions from the vaccine or possibly from Borrelia burgdorferi infection," she said. B. burgdorferi is the bacterium that is transmitted by infected ticks to humans, causing a wide spectrum of symptoms, from rash to neurological impairment.
Dr. Sander noted that the investigators have only been tracking these neurological complications for a year. "We want to put it on the map that the vaccine can be linked to these conditions. This is just the tip of the iceberg," she said.
Dr. Armin Alaedini, PhD, also a fellow in neurology and another co-author of the study, noted that in hearings before the Food and Drug Administration many individuals reported a variety of symptoms following Lymerix vaccination.
The researchers scrutinised the genetic sequencing of key amino acids found in the patients and in various databases. They said their work considered that the neurological sequelae of Lymerix vaccination, and possibly chronic Lyme disease, might be caused by molecular mimicry, resulting from reactions to part of the vaccine proteins.
Dr. Wu said one patient suffering from a neuropathy had responded to standard treatments. She said that the presentation did not receive any outside funding.
www.pslgroup.com/dg/220652.htm
All emphasis mine.